GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut. Show more
Location: North Tower, Stamford, CT, 06902, United States | Website: https://www.genedx.com | Industry: Diagnostics & Research | Sector: Healthcare
Market Cap
3.397B
52 Wk Range
$48.95 - $136.00
Previous Close
$117.37
Open
$117.55
Volume
658,865
Day Range
$116.23 - $121.57
Enterprise Value
3.351B
Cash
134.6M
Avg Qtr Burn
N/A
Insider Ownership
12.33%
Institutional Own.
-
Qtr Updated
06/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|